Concepedia

Fathima Zumla Cader

FZ

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

2012

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

University of Birmingham

University of Washington

Fathima Zumla Cader is an author at Brigham and Women's Hospital specializing in life sciences, cancer immunology, and immunology.

ORCID

Publications per year

2012–2024

8

Publications

8

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma

Margaretha G.M. Roemer, Robert Redd, Fathima Zumla Cader et al. · Journal of Clinical Oncology · 2018 · 367 citations · Full text

, , +17

Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell–rich and exhausted T-effector microenvironment

Fathima Zumla Cader, Ron C.J. Schackmann, Xihao Hu et al. · Blood · 2018 · 165 citations · Full text

, , +17

Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion

Kirsty Wienand, Bjoern Chapuy, Chip Stewart et al. · Blood Advances · 2019 · 165 citations · Full text

, , +14

EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors

Robert E. White, Patrick C. Rämer, Kikkeri N. Naresh et al. · Journal of Clinical Investigation · 2012 · 163 citations

, , +17

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

Fathima Zumla Cader, Xihao Hu, Walter L. Goh et al. · Nature Medicine · 2020 · 140 citations · Full text

, , +16

1–5 of 8